Comparative efficacy and safety of ocrelizumab in relapsing-remitting and primary progressive multiple sclerosis: A systematic review and meta-analysis
Abstract Objective This meta-analysis synthesizes evidence from all available randomized trials and observational cohort studies evaluating the efficacy and safety of ocrelizumab compared to placebo or active comparator therapies. Background Ocrelizumab (OCR), a monoclonal antibody targeting CD20-po...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-11-01
|
| Serier: | BMC Neurology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12883-025-04519-4 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
